Description

Inakalant CAS NO 335619-18-6 is a high-purity pharmaceutical intermediate and research chemical of significant interest in medicinal chemistry. This compound is valued for its role as a key building block in the synthesis of novel therapeutic agents, particularly in the cardiovascular and antiarrhythmic research domains. It is essential for pharmaceutical R&D laboratories, contract manufacturing organizations (CMOs), and academic institutions engaged in drug discovery and development.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of advanced active pharmaceutical ingredients (APIs) for cardiovascular applications.
• Medicinal Chemistry Research: Used as a scaffold or building block for designing and optimizing new chemical entities in drug discovery programs.
• Biochemical Research: Employed in pharmacological studies to investigate ion channel modulation and related biological pathways.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Contract Synthesis: Supplied to CMOs and CDMOs for custom synthesis and scale-up projects under cGMP conditions.

Basic Information

Product Name	Inakalant
CAS No.	335619-18-6
Molecular Formula	C19H24N2O3
Molecular Weight	328.41 g/mol
Synonyms	N-[2-[4-[(4-Fluorophenyl)methyl]-1-piperidinyl]ethyl]-3,4-dimethoxybenzamide; Inakalant; BMS-308762; (R)-N-[2-[4-[(4-Fluorophenyl)methyl]-1-piperidinyl]ethyl]-3,4-dimethoxybenzamide; Benzamide, N-[2-[4-[(4-fluorophenyl)methyl]-1-piperidinyl]ethyl]-3,4-dimethoxy-; BMS308762
EINECS	Contact for details

Quality Control

Our Inakalant is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. We provide comprehensive analytical data supporting identity, purity, and impurity profiles. Certificates of Analysis (COA) are available for every batch, detailing results from advanced analytical techniques such as HPLC, NMR, and MS. Our quality commitment aligns with the standards expected for pharmaceutical R&D and cGMP intermediate production.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The product should be kept under an inert atmosphere if long-term storage is required to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 98.0%
Purity (HPLC)	≥ 99.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.